Restoration Therapeutics

Restoring healthy cellular function

Cells are the foundation of every tissue, organ and biological system. When cellular function declines, disease follows. We believe restoring healthy cellular function can open a new class of therapeutics that address many conditions through a shared underlying cause.

Medicine became powerful by understanding diseaseThe next generation may come from understanding function

Many conditions emerge alongside the gradual loss of healthy cellular function. If that function can be restored safely, a new class of therapeutics may become possible.

On the left, individual diseases such as Parkinson's, Alzheimer's and fibrosis are each treated through a single target and therapy. On the right, one cellular function hub connects to multiple cell types: astrocytes, neurons, microglia, fibroblasts and melanocytes.
BioRes logo

Understanding disease has given us incredible therapies. Understanding and restoring function may unlock what comes next.

We are building the science, tools and platforms to explore this possibility.

The platform

Safety is the bridge between possibility and medicine

Powerful restoration technologies have emerged from decades of biological research.

The challenge is not whether cellular function can be influenced.

The challenge is doing so with the safety, control and repeatability required for medicine.

BioRes is building restoration therapeutics around these principles from the beginning.

BioRes platform principles Safety at the centre, supported by three principles: Control, Repeatable and Non-genomic. CONTROL Designed for transient, tunable exposure, not permanent change. REPEATABLE Built for redosing and long-term therapeutic management. NON-GENOMIC Restoring function without altering the underlying genetic code. SAFETY

Restoration programs

Not one diseaseA new therapeutic category

Medicine has traditionally advanced one disease at a time. Restoration therapeutics begins from a different premise: many conditions emerge when cells lose healthy function.

By restoring function in specific cell types, a single platform can create multiple therapeutic opportunities across diseases, tissues and indications. Each program expands the map.

Complete In discussion Planned

Neural Restoration

MK Series

Restoring healthy function in the brain and nervous system.

DesignValidationFundingPharma
Astrocytes
ApplicationsAlzheimer's diseaseParkinson's diseaseALS
Microglia
ApplicationsAlzheimer's diseaseParkinson's diseaseMultiple sclerosis
Dopaminergic Neurons
ApplicationsParkinson's diseaseDementia with Lewy bodiesMultiple system atrophy
Oligodendrocytes
ApplicationsMultiple sclerosisParkinson's diseaseMultiple system atrophy

Skin Restoration

RES Series

Restoring healthy function in skin and connective tissue.

DesignValidationFundingPharma
Fibroblasts
ApplicationsCosmetic restorationWound healingFibrosis
Keratinocytes
ApplicationsWound healingPsoriasisEczema
Melanocytes
ApplicationsMelanomaVitiligoPigmentation disorders

Each successful program expands an entirely new therapeutic category. The platform is designed to extend across additional cell types and tissues over time.

The restoration map

A new category across systems

Active programs Planned exploration
The restoration mapRestoration Therapeutics at the centre, with active programs in Neural and Skin, and planned exploration across immune, cardiovascular, metabolic, musculoskeletal, reproductive and respiratory systems. RESTORATION THERAPEUTICS Restoring healthycellular functionacross the body NEURAL Restoring function inthe brain and nervoussystem IMMUNE Restoring immunebalance and functionacross conditions CARDIOVASCULAR Exploring restorationof vascular andcardiac cell health METABOLIC Exploring metabolichealth and energyregulation MUSCULOSKELETAL Exploring muscle, boneand connective tissuerestoration SKIN Restoring skinstructure, functionand regeneration REPRODUCTIVE Restoring reproductivecell health andhormonal balance RESPIRATORY Exploring lung andairway cell functionrestoration

Partners & ecosystem

Building restoration therapeutics with the ecosystem it requires

Restoring cellular function is not a single-company effort. It requires deep biology, translational infrastructure, disease expertise, regulatory insight and partners committed to advancing the field responsibly.

BioRes is building alongside leading research environments, collaborators and disease-focused organisations to help move restoration therapeutics from possibility toward medicine.

Translational lab infrastructure and UK biotech ecosystem

Cambridge innovation network

Collaborators across the field

Research collaborators

Academic and technical partners supporting cellular models, restoration assays and mechanistic validation.

Pharma collaborators

Strategic partners exploring translational validation, disease models and future therapeutic development.

Disease foundation collaborators

Patient-focused organisations helping align restoration biology with urgent clinical need.

Consortium partners

Organisations contributing to shared standards, responsible development and the emerging restoration therapeutics field.

Restoration therapeutics will be built through collaboration.

Team

Building the team this challenge deserves

Restoring healthy cellular function demands expertise that no single discipline can provide.

BioRes is bringing together scientists, engineers and builders across biology, protein engineering, delivery science and translational medicine, united by one ambition: to make restoration therapeutics a reality.

Meet the people
Disciplines converging on restoration therapeutics Biology, protein engineering, delivery science, AI, translational medicine, clinical development and regulatory science converging toward restoration therapeutics. BIOLOGYPROTEIN ENGINEERINGDELIVERY SCIENCEAITRANSLATIONAL MEDICINECLINICAL DEVELOPMENTREGULATORY SCIENCE Restoration Therapeutics

Help define where medicine goes next

For scientists, partners, investors and disease-focused organisations working to make Restoration Therapeutics a reality.